Anzeige
Mehr »
Login
Mittwoch, 24.04.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Breaking News: InnoCan startet in eine neue Ära – FDA Zulassung!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
94 Leser
Artikel bewerten:
(0)

Research and Markets - Global Cold Pain Therapy Market 2016-2021 by Product and Application with Hisamitsu Pharmaceutical, Breg Inc & 3M Company Dominating

DUBLIN, October 26, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "Cold Pain Therapy Market by Product and by Application - Forecast to 2021" report to their offering.

The global market is estimated to grow at a CAGR of 5.0% from 2016 to 2021 to reach USD 1087.7 Million by 2021

The growth in this market is primarily driven by the rising incidence of sports injuries, growing need for safe pain management modalities, and rising regulatory barriers for oral pain medications. Cold pain therapy produces cooling sensations at the site of pain and alleviates the same instantly by distracting the mind from the pain.

Based on product, the market is categorized into OTC and prescription-based products. OTC-based cold pain therapy products are segmented into pharmaceuticals (gels, ointments, and creams, sprays and foams, patches, and roll-ons) and medical devices (cold packs, cooling towels, compresses, wraps, and pads) whereas the prescription-based devices are classified into motorized and non-motorized devices. The OTC segment is expected to command the largest market share in 2016, primarily due to the easy availability of these products without prescription.

On the basis of application, the market is segmented into musculoskeletal disorders, sport medicine, post-operative, post-trauma, and physical therapy. The musculoskeletal disorders segment is expected to witness the highest market share in 2016 due to the increasing number of individuals suffering from arthritis, osteoarthritis, back pain, and joint pain; and the rising proportion of geriatric population.

In 2016, North America accounted for the largest share of the global market, followed by Europe. The Asia-Pacific market is projected to grow at the highest CAGR during the forecast period. Factors such as the long-term market presence of key cold pain therapy players with established product portfolios in the region and a high preference for topical analgesics are stimulating the growth of the APAC market.

Cold Pain Therapy Market

Hisamitsu Pharmaceutical Co. Inc. (Japan), Breg Inc. (U.S.), and 3M Company (U.S.) were the top players in the market in 2015. Agreements and contracts were the top strategies employed by the leading players in the market.

Key Topics Covered:

1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview

6 Cold Pain Therapy Market, By Product

7 Cold Pain Therapy Market, By Application

8 Cold Pain Therapy Market, By Region

9 Competitive Landscape

10 Company Profiles

  • 3M Company
  • Beiersdorf AG
  • Breg, Inc.
  • DJO Finance LLC
  • Hisamitsu Pharmaceutical Co., Inc.
  • Johnson & Johnson
  • Medline Industries, Inc.
  • Össur HF
  • Rohto Pharmaceutical Co., Ltd.
  • Sanofi

For more information about this report visit http://www.researchandmarkets.com/research/wg5kmk/cold_pain_therapy

About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.